Management of depression in patients with schizophrenia spectrum disorders: a critical review of international guidelines.

Further studies are needed to strengthen the level of evidence for antidepressive approaches in PWS. The inclusion of PWS as stakeholders is also considered to be a major issue for future guideline development.